Kestra Medical Technologies, Ltd.
KMTS
$20.70
$1.115.67%
NASDAQ
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 83.72M | 74.26M | 66.40M | 59.82M | 52.64M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 83.72M | 74.26M | 66.40M | 59.82M | 52.64M |
| Cost of Revenue | 42.91M | 39.80M | 37.54M | 35.61M | 34.66M |
| Gross Profit | 40.81M | 34.46M | 28.86M | 24.21M | 17.97M |
| SG&A Expenses | 165.19M | 146.28M | 129.44M | 114.94M | 82.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 227.33M | 203.71M | 183.23M | 166.19M | 131.15M |
| Operating Income | -143.61M | -129.45M | -116.83M | -106.38M | -78.52M |
| Income Before Tax | -143.68M | -131.29M | -119.16M | -113.68M | -84.98M |
| Income Tax Expenses | 204.00K | 187.00K | 161.00K | 135.00K | 6.00K |
| Earnings from Continuing Operations | -143.89 | -131.48 | -119.32 | -113.81 | -84.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -942.00K | -692.00K | -439.00K | 0.00 | 942.00K |
| Net Income | -144.83M | -132.17M | -119.76M | -113.81M | -84.05M |
| EBIT | -143.61M | -129.45M | -116.83M | -106.38M | -78.52M |
| EBITDA | -135.39M | -121.32M | -109.20M | -98.41M | -68.88M |
| EPS Basic | -4.00 | -4.64 | -5.19 | -5.81 | -4.78 |
| Normalized Basic EPS | -2.43 | -2.72 | -2.96 | -3.26 | -2.57 |
| EPS Diluted | -4.00 | -4.64 | -5.19 | -5.81 | -4.78 |
| Normalized Diluted EPS | -2.43 | -2.72 | -2.96 | -3.26 | -2.57 |
| Average Basic Shares Outstanding | 183.11M | 147.15M | 115.66M | 84.24M | 79.54M |
| Average Diluted Shares Outstanding | 183.11M | 147.15M | 115.66M | 84.24M | 79.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |